Q3 2024 Adaptimmune Therapeutics PLC Earnings Call Transcript
Hello, and welcome to the Adaptimmune Therapeutics third-quarter 2024 results conference call. (Operator Instructions)
I will now turn the call over to Dan Od-Cohen, Investor Relations for Adaptimmune. Dan, please go ahead.
Thank you, operator. Good afternoon, everyone, and welcome to Adaptimmune's conference call to discuss our third-quarter 2024 financial results and business updates. I would ask you to review the full text of our forward-looking statements from this morning's press release. We anticipate making projections during this call and actual results could differ materially due to several factors, including those outlined in our latest filings with the SEC.
Adrian Rawcliffe, our Chief Executive Officer, is here with me for the prepared portion of the call, and other members of our leadership team will be available for Q&A. With that, I'll turn the call over to Adrian Rawcliffe. Over to you, Ad.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |